Roger A Barker
Roger A Barker
Verified email at
Cited by
Cited by
RNA velocity of single cells
G La Manno, R Soldatov, A Zeisel, E Braun, H Hochgerner, V Petukhov, ...
Nature 560 (7719), 494-498, 2018
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
I Litvan, JG Goldman, AI Tröster, BA Schmand, D Weintraub, RC Petersen, ...
Movement disorders 27 (3), 349-356, 2012
A functional role for adult hippocampal neurogenesis in spatial pattern separation
CD Clelland, M Choi, C Romberg, GD Clemenson Jr, A Fragniere, ...
Science 325 (5937), 210-213, 2009
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
CH Williams-Gray, T Foltynie, CEG Brayne, TW Robbins, RA Barker
Brain 130 (7), 1787-1798, 2007
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
CH Williams-Gray, JR Evans, A Goris, T Foltynie, M Ban, TW Robbins, ...
Brain 132 (11), 2958-2969, 2009
Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands
R Cools, RA Barker, BJ Sahakian, TW Robbins
Cerebral cortex 11 (12), 1136-1143, 2001
Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease
AA Kehagia, RA Barker, TW Robbins
The Lancet Neurology 9 (12), 1200-1213, 2010
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis
D Aarsland, K Bronnick, C Williams-Gray, D Weintraub, K Marder, ...
Neurology 75 (12), 1062-1069, 2010
The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study
T Foltynie, CEG Brayne, TW Robbins, RA Barker
Brain 127 (3), 550-560, 2004
Molecular diversity of midbrain development in mouse, human, and stem cells
G La Manno, D Gyllborg, S Codeluppi, K Nishimura, C Salto, A Zeisel, ...
Cell 167 (2), 566-580. e19, 2016
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
CH Williams-Gray, SL Mason, JR Evans, T Foltynie, C Brayne, ...
Journal of Neurology, Neurosurgery & Psychiatry 84 (11), 1258-1264, 2013
Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry
SJG Lewis, A Dove, TW Robbins, RA Barker, AM Owen
Journal of Neuroscience 23 (15), 6351-6356, 2003
Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach
SJG Lewis, T Foltynie, AD Blackwell, TW Robbins, AM Owen, RA Barker
Journal of Neurology, Neurosurgery & Psychiatry 76 (3), 343-348, 2005
L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease
R Cools, RA Barker, BJ Sahakian, TW Robbins
Neuropsychologia 41 (11), 1431-1441, 2003
Targeting huntingtin expression in patients with Huntington’s disease
SJ Tabrizi, BR Leavitt, GB Landwehrmeyer, EJ Wild, C Saft, RA Barker, ...
New England Journal of Medicine 380 (24), 2307-2316, 2019
Cognitive impairment in Parkinson’s disease: the dual syndrome hypothesis
AA Kehagia, RA Barker, TW Robbins
Neurodegenerative diseases 11 (2), 79-92, 2012
The spectrum of nonmotor symptoms in early Parkinson disease
TK Khoo, AJ Yarnall, GW Duncan, S Coleman, JT O’Brien, DJ Brooks, ...
Neurology 80 (3), 276-281, 2013
Microglial activation correlates with severity in Huntington disease: a clinical and PET study
N Pavese, A Gerhard, YF Tai, AK Ho, F Turkheimer, RA Barker, DJ Brooks, ...
Neurology 66 (11), 1638-1643, 2006
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
S Palfi, JM Gurruchaga, GS Ralph, H Lepetit, S Lavisse, PC Buttery, ...
The Lancet 383 (9923), 1138-1146, 2014
A cell atlas of human thymic development defines T cell repertoire formation
JE Park, RA Botting, C Domínguez Conde, DM Popescu, M Lavaert, ...
Science 367 (6480), eaay3224, 2020
The system can't perform the operation now. Try again later.
Articles 1–20